Biostate AI closes $12M to bring the Netflix model to molecular diagnostics

Biostate AI, a leading innovator in artificial intelligence and RNA sequencing, announced the successful completion of a $12M Series A funding round, led by Accel. The company’s immediate focus is revolutionizing RNAseq accessibility and developing clinically relevant predictive models. 

Read more here.

Previous post
Back to list
Next post